Delivery Order SPE2DB20D3101-SPE2DB23FRYC1
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ozempic 0.25-0.5 mg/dose pen 3 mL. The contract has a firm fixed price of $20,789.64 and an ultimate completion date of September 10, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Ozempic 0.25-0.5 mg/dose pens in 3 mL size. The contract has a ceiling value of $25,793.47 and a period of performance through May 3, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical,...
- This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic (0.25-0.5 mg/dose) medication in 3 mL pens. The award, valued at $6,522.04, is a Firm Fixed Price Delivery Order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, worth up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $49,120.20, is a delivery order for the supply of Ozempic 0.25-0.5 mg/dose pens. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,714.46, is a delivery order for the supply of Ozempic 0.25-0.5 mg/dose pen 3 ml. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ozempic 0.25-0.5 mg/dose pen 3ml. The contract has a ceiling value of $11,533.04 and is a Firm Fixed Price Delivery Order running through December 17, 2024. The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,987.50 firm fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pen in a 3 mL size. The contract has an ultimate completion date of January 13, 2025 and was awarded on January 10, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ozempic 0.25-0.5 mg/dose pen 3 mL. The contract has a firm-fixed price of $7,328.68 and an ultimate completion date of January 12, 2024. This award is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. (doing business as AmerisourceBergen) with the DLA Troop Support Medical, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Ozempic 0.25-0.5 mg/dose pens. The contract is a firm-fixed-price delivery order with a ceiling value of $50,768.51 and an ultimate completion date of September 25, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic 0.25-0.5 mg/dose pen 3ml. The award, valued at $2,385.50, is a delivery order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a potential value of up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical and medical...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB23FRYC1Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Ozempic 0.25-0.5 mg/dose pen 3ml. The award, valued at $32,651.50, is a delivery order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through November 2026. The contract supports the procurement of a wide range of pharmaceutical products, medical supplies, and other healthcare commodities for military treatment facilities, veterans' healthcare programs, and other federal medical institutions. This contract award was made through full and open competition without any set-aside designations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.7k | 9/18/23 |